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Abstract Myxoid liposarcomas (MLSs) with extensive
lipoma-like changes (MLSLC) are rare, and it is often difficult
to distinguish them fromwell-differentiated liposarcoma (LS)/
dedifferentiated LS (WDLS/DDLS) with myxoid changes.
For the characterization of these neoplasms, we studied 8
MLSLCs, 11 ordinary MLSs, 4 WDLSs, and 6 DDLSs. Cy-
togenetically, MLSLC and ordinary MLS were characterized
by t(12;16)(q13;p11) and FUS-DDIT3 fusion gene, whereas
WDLS/DDLS lacked the fusion gene but possessed giant
marker/ring chromosomes. Both lipoma-like and myxoid
components of the same MLSLC exhibited the identical
FUS-DDIT3, as confirmed by fluorescence in situ hybridiza-
tion (FISH) and reverse transcription polymerase chain reac-
tion (RT-PCR). Immunohistochemically, MDM2 and CDK4
were positive in WDLS/DDLS but negative in MLSLC and
ordinary MLS. PPARγ, C/EBPα, adipophilin, and perilipin
were found in each type of LS. Adipophilin was expressed
chiefly in tiny fat droplets of immature lipoblasts, whereas
perilipin showed a strong positive staining in large fat
vacuoles of signet ring and multivacuolated lipoblasts. The
Ki-67 labeling index was lower in the lipoma-like component
of MLSLC when compared with the myxoid component of
the same tumors as well as ordinary MLS (p<0.001). When
compared with ordinary MLS, MLSLC may be less aggres-
sive in clinical behavior (rare recurrences or metastases) after
a wide surgical excision. In conclusion, the distinction be-
tween MLSLC and WDLS/DDLS is important, because of
the differences of molecular cytogenetic features as well as
clinical behaviors between these distinct sarcomas presenting
similar morphologic features. In addition, the combined im-
munohistochemical detection of adipophilin and perilipin may
provide a useful ancillary tool for identification of lipoblastic
cells in soft tissue sarcomas.
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Introduction
Myxoid liposarcoma (MLS) is the second most common type
of liposarcoma (LS) after atypical lipomatous tumor/well-
differentiated LS (ALT/WDLS) [1, 2]. MLS usually presents
as a large painless mass within the deep soft tissue of the
extremities in young adults and middle-aged individuals. His-
tologically, MLS is composed of predominantly uniform
round- to oval-shaped primitive mesenchymal cells admixed
with signet ring or multivacuolated lipoblasts in a prominent
myxoid stroma, which is rich in a delicate arborizing “chick-
en-wire” capillary vasculature. Included in this category are
lesions formerly known as round cell LS (RCLS)
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characterized by hypercellular round cell morphology, which
is associated with a significantly poor prognosis [1–3].
Although a variable number of signet ring lipoblasts are
found in MLS, extensive mature adipocytic differentiation
forming a lipoma-like component is very rare [4–6]. Morpho-
logically, it is often difficult to distinguishMLSwith extensive
lipoma-like changes (MLSLC) from ALT/WDLS with
myxoid changes, but the severe degree of nuclear atypia
may help to exclude MLS/MLSLC [7]. Cytogenetically, most
cases of MLS show specific chromosomal translocation
t(12;16)(q13;p11) resulting in the formation of a FUS-DDIT3
(also known as TLS-CHOP) fusion transcript [8–17], although
occasional tumors exhibit the variant t(12;22) (q13;q12), pro-
ducing an EWSR1-DDIT3 fusion transcript [1, 18]. On the
other hand, ALT/WDLS is characterized by supernumerary
ring chromosome and/or giant markers with amplification of
the 12q13~q15 region, which is often associated with over-
expression of CDK4 and MDM2 [1, 17, 19–23].
Myxoid areas within ALT/WDLS and dedifferentiated LS
(DDLS) sometimes possess a prominent plexiform vascularity
with thin-walled arborizing capillaries, creating a resemblance
to MLS especially when interspersed small fat cells are pres-
ent [7, 24–26]. On the basis of molecular and immunohisto-
chemical studies, de Vreeze et al. [24] suggested that apparent
primary retroperitoneal MLS/RCLS could be recognized as
WDLS/DDLS with morphological features mimicking MLS/
RCLS. They considered that finding of the MLS-specific
translocations (fusion genes) in a retroperitoneal LS is highly
suggestive of metastasis and should prompt search for a pri-
mary lesion outside the retroperitoneum.
In addition, rare cases of mixed-type LS composed of an
admixture of MLS and WDLS have been reported by some
investigators [17, 27]. More recently, Deyrup et al. [28] re-
ported a new group of “fibrosarcoma-like lipomatous neo-
plasm,” which were composed of low-grade spindle cells
showing varying degrees of lipoblastic differentiation and
sometimes accompanied by abundant myxoid stoma and
thin-walled arborizing capillaries similar to those of MLS,
but these tumors lacked molecular cytogenetic characteristics
of other types of lipomatous tumors.
The development of normal fat cells is considered to be
regulated by various factors including peroxisome
proliferator-activated receptor-γ (PPARγ) and CCAAT/en-
hancer-binding protein-α (C/EBPα) [29]. PPARγ may regu-
late the expression of lipid droplet-associated proteins includ-
ing adipophilin and perilipin in normal tissues [30, 31], but
little is known about the mechanism of adipocytic differenti-
ation in MLSLC.
In order to clarify the true nature of rare lipomatous differ-
entiation in MLS, we studied eight cases of MLSLC, by using
immunohistochemistry (MDM2, CDK4, PPARγ, C/EBPα,
adipophilin, perilipin, and Ki-67), chromosome analysis, fluo-
rescence in situ hybridization (FISH), and reverse
transcription polymerase chain reaction (RT-PCR). In addi-
tion, ordinary MLS (11 cases), WDLS (4 cases), and DDLS
(6 cases) were studied as controls. To our knowledge, this is
the first report describing the detailed molecular cytogenetic
and clinicopathologic features of MLSLC.
Materials and methods
Tumor material and patient data
The consultation and archival files of molecular cytogenetic
analysis of soft tissue tumors in the Department of Pathology,
Fukuoka University School of Medicine, between 1987 and
2012 were searched for MLS with or without well-
differentiated lipoma-like components. Eight cases of
MLSLC were selected for the present study. In addition, 11
cases of ordinary MLS without lipoma-like components, 4
cases of WDLS, and 6 cases of dedifferentiated LS (DDLS)
with myxoid changes were studied as controls.
Clinical parameters, including gender, age, location, and
macroscopic features, were obtained from medical records.
In all cases, histologic sections were available for pathologic
review, and the diagnosis was confirmed according to the
WHO (2013) classification. Formalin-fixed and paraffin-
embedded tumor tissues available in each case were used for
immunostaining and molecular analysis. In 16 cases, fresh
tumor tissues were utilized for chromosomal analysis as well
as molecular study. Follow-up information was obtained from
the referring clinicians and from the existing medical records
in accord with institutional guidelines.
Immunohistochemical staining
For immunohistochemistry, 3-μm-thick paraffin-embedded
tissue sections were mounted on silane-coated glass slides,
deparaffinized, and heated in antigen retrieval buffer using a
pressure cooker for 10 min or a microwave for 30 min. The
following primary antibodies were used: MDM2 (dilution
1/100; Calbiochem, Darmstadt, Germany), CDK4 (dilution
1/200; Invitrogen, Camarillo, CA), PPARγ (dilution 1/100;
Perseus Proteomics, Tokyo, Japan), C/EBPα (dilution 1/200;
Cell Signaling Technology, Danvers, MA), adipophilin (dilu-
tion 1/20; Fitzgerald, Acton, MA), perilipin (dilution 1/200;
Cell Signaling Technology, Danvers, MA), and Ki-67 (clone
MIB-1, dilution 1/200; Dako, Glostrup, Denmark). Immuno-
histochemical staining was performed by using the Nichirei
Histofine Simple Stain MAX PO (MULTI) (Nichirei Biosci-
ences Inc., Tokyo, Japan). The reactions were visualized with
diaminobenzidine, and the sections were counterstained with
Mayer’s hematoxylin. For MDM2, CDK4, PPARγ, C/EBPα,
adipophilin, and perilipin, the immunoreactivity was graded
semiquantitatively as negative (0 %), 1+ (<25 % of neoplastic
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cells reactive), 2+ (25 to 50% of neoplastic cells reactive), and
3+ (>50 % of neoplastic cells reactive). The Ki-67 labeling
index was obtained as a percentage of positive nuclei by
counting 500 neoplastic cells within the areas exhibiting the
highest labeling index (hot spots). The Mann-Whitney U test
was used to compare the differences of the Ki-67 index.
Cytogenetic analysis
Primary cell cultures, harvesting, and preparation of slides were
carried out as previously described [9, 21, 22]. Chromosome
analysis was performed on GTG-banded (Giemsa/trypsin) meta-
phases, and the karyotypes were described according to the In-
ternational System for Human Cytogenetic Nomenclature [32].
FISH analysis for DDIT3 break apart
FISH was performed on paraffin-embedded tissue sections
(cases 1–8, 12, 13, 17, 18, 21–25), by using a commercially
available DDIT3 (CHOP) (12q13) Dual Color, Break Apart
Rearrangement Probe (Abbott Molecular Inc.). Briefly, 4-μm-
thick paraffin-embedded tissue sections were deparaffinized,
dehydrated, and incubated with protease and pretreated by the
Vysis Paraffin Pretreatment IV & Post-Hybridization Wash
Buffer Kit (Abbott Molecular Inc.) according to the manufac-
turer’s instructions [4, 33]. The probe and slides were
codenatured at 80 °C for 5 min and incubated at 37 °C over-
night in a humidified chamber. Posthybridization washingwas
performed following standard procedures, and the nuclei were
counterstained with DAPI. The slides were examined using a
fluorescence microscope with appropriate excitation and
emission filters. At least 100 morphologically intact, nonover-
lapping nuclei of tumor cells from either myxoid or lipoma-
tous areas were counted. FISH was considered rearranged if
more than 10% of nuclei showed break apart of the dual-color
probe signal for the targeted locus.
RT-PCR for FUS-DDIT3
RNAwas extracted from fresh-frozen tumor tissues (cases 1,
2, 6–12, 14–21, 23–25, 27–29) as well as formalin-fixed and
paraffin-embedded tumor samples (cases 1, 3–8, 13, 22, 26)
by using TRIzol® reagent (Life Technologies Japan, Tokyo,
Japan) according to the manufacturer’s recommendations. In
seven cases of MLSLC (cases 1, 3–8), the paraffin sections
were dissected under a microscope, and the samples were
taken separately from myxoid and lipoma-like components,
which were simultaneously identified by examining the adja-
cent serial sections stained with H & E.
RNA was reverse transcribed into complementary DNA
(cDNA) by PrimScript® II first-strand cDNA Synthesis Kit
(Takara Bio, Tokyo, Japan). The PCR to amplify a cDNA that
corresponds toFUS-DDIT3 fusion genewas performed by using
KOD-Plus-Ver. 2 (Toyobo, Tokyo, Japan) with the FUS ex5 and
DDIT3 primer set amplifying a 160-bp (FUS-DDIT3 type II)
fragment and a 436-bp (FUS-DDIT3 type I) fragment or the
FUS ex7 and DDIT3 primer set amplifying a 129-bp (FUS-
DDIT3 type I) fragment, according to Powers et al. [34]. PCR
products were analyzed by Microchip Electrophoresis System




Clinical information of 29 patients examined is summarized in
Table 1. One of five MLSLCs and four of nine ordinary MLSs
with follow-up data showed local recurrences. As for WDLS
and DDLS, all six retroperitoneal tumors recurred after surgery,
whereas four tumors arising in the extremities exhibited no
recurrences after a complete wide excision. A remotemetastasis
was found in oneMLSLC, two ordinaryMLSs, and oneDDLS.
One patient with retroperitoneal DDLS was dead of disease
Macroscopic features
Grossly, MLSs were multinodular or lobulated and often in-
volved the skeletal muscle. The size of tumor was described in
six cases of MLSLC, ranging from 7 to 13 cm in the greatest
dimension (mean, 9.5 cm; median, 9.5 cm). All eight tumors
of MLSLC contained lipoma-like yellowish areas in varying
proportions (30–90 %), admixed with myxoid areas resem-
bling ordinary MLS. Foci of necrosis and hemorrhage were
found in the large tumors (cases 5 and 8). The myxoid areas of
MLSLC and ordinary MLS were typically gelatinous, jelly-
like with an abundant myxoid substance.
WDLSs were characterized by large yellowish masses lob-
ulated by fibrous septa. Foci of sclerosis and myxoid changes
were often observed. DDLS generally exhibited yellowish
lipoma-like components, coexisting with solid gray-whitish
areas corresponding to the dedifferentiation. Proportion of
lipoma-like to dedifferentiated components varied from tumor
to tumor, and one DDLS was composed almost completely of
a dedifferentiated component (case 29).
Histologic features
All eight tumors of MLSLC contained lipoma-like well-dif-
ferentiated component comprising 30–90 % (mean 49 %) of
the mass (Table 1, Figs. 1 and 2a, b), whereas the remaining 11
control cases of ordinary MLS lacked distinct lipoma-like
components. The lipoma-like components ofMLSLC showed
abundant mature adipocytes with considerable variation in
cellular size (Figs. 1 and 2a), bearing superficial resemblance
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to WDLS (Fig. 2e). In most tumors of MLSLC, there were
gradual transitional zones (Fig. 2b) between the myxoid and
lipoma-like components, but some tumor demonstrated focal-
ly sharp borders (Fig. 1) between the two components (cases 5
and 8). However, no significant difference of histologic fea-
tures was found between the myxoid areas of MSLLC and
ordinary MLS (Fig. 2c, d). The myxoid areas were made up
of a proliferation of small round or stellate cells loosely float-
ing in an abundant myxoid stroma, rich in delicate arborizing
capillary blood vessels. Varying numbers of lipoblasts includ-
ing univacuolated signet ring cells and some small
multivacuolated cells were admixed with immature round or
stellate cells, but typical spiderweb or giant lipoblasts with
bizarre hyperchromatic nuclei were absent.
In all four cases of WDLS, tumors were composed of pre-
dominant mature adipocytes interspersed with varying
number of atypical cells having hyperchromatic nuclei
(Fig. 2e). Multivacuolated lipoblasts with spiderweb features
were observed among the tumor cells. Ill-defined focal
myxoid areas with spindle or stellate cells were commonly
seen in WDLS. DDLS (six cases) contained well-defined
nonlipogenic dedifferentiated areas (Fig. 2f–h) in addition to
the lipoma-like well-differentiated areas. Both components
were usually seen in the same DDLS, but one tumor was
composed almost completely of a dedifferentiated component
(case 29). The dedifferentiated areas consisted mainly of a
high-grade pleomorphic/spindle cell component reminiscent
of malignant fibrous histiocytoma (Fig. 2g), but varying de-
grees ofmyxoid changes (Fig. 2f, h) were observed in all cases
of DDLS examined. In case 24, recurrent DDLS showed
prominent cartilaginous metaplasia as well as a low-grade
fibromatosis-like component.
Table 1 Clinicopathologic features of liposarcomas with or without lipoma-like component





1 23 F rt. lower leg MLSLC 40 Wide excision 66 No No ANED
2 66 M rt. lower leg MLSLC 40 Wide excision 25 Yes, 1 Yes, 1 ANED
3 75 M lt. thigh MLSLC 50 Excision NA LTF
4 35 F rt. lower leg MLSLC 30 Excision NA LTF
5 74 M lt. thigh MLSLC 90 Excision NA LTF
6 66 F lt. thigh MLSLC 30 Wide excision 27 No No ANED
7 66 M rt. groin MLSLC 70 Wide excision 23 No No ANED
8 51 M rt. thigh MLSLC 40 Wide excision 8 No No ANED
9 28 M Mediastinum MLS 0 Excision 60 Yes, 1 Yes, 1 AWD
10 39 F lt. poplitea MLS 0 Wide excision 71 No No ANED
11 39 F lt. thigh MLS 0 Excision NA LTF
12 35 M lt. thigh MLS 0 Wide excision 75 Yes, 3 No ANED
13 52 F lt. thigh MLS 0 Wide excision 62 Yes, 1 No ANED
14 54 M Retroperitoneum MLS 0 Wide excision 8 Yes, 2 Yes, 1 AWD
15 44 F Thoracic wall MLS 0 Wide excision NA LTF
16 48 M lt. knee MLS 0 Wide excision 22 No No ANED
17 53 F lt. lower leg MLS 0 Wide excision 52 No No ANED
18 36 M r. buttock MLS 0 Wide excision 54 No No ANED
19 36 F rt. ankle MLS 0 Wide excision 51 No No ANED
20 69 M rt. thigh WDLS 80 Wide excision 49 No No ANED
21 48 F Retroperitoneum WDLS 70 Excision 69 Yes, 3 No AWD
22 67 F Retroperitoneum WDLS 95 Excision NA Yes, 1 LTF
23 74 F lt. thigh WDLS 98 Wide excision 23 No No ANED
24 50 F Retroperitoneum DDLS 40 Excision 104 Yes, 3 Yes AWD
25 61 M Retroperitoneum DDLS 20 Excision 7 Yes, 1 No AWD
26 73 F Retroperitoneum DDLS 70 Incomplete Excision 138 Yes, 1 No DOD
27 58 F Retroperitoneum DDLS 10 Excision 25 Yes, 1 No ANED
28 83 F rt. thigh DDLS 5 Wide excision 33 No No ANED
29 79 F lt. lower leg DDLS 0 Wide excision 9 No No ANED
ANED alive and no evidence of disease, AWD alive with disease,DDLS dedifferentiated liposarcoma,DOD dead of disease, LTF lost to follow-up,MLS
myxoid liposarcoma, MLSLC MLS with lipoma-like component, WDLS well-differentiated liposarcoma
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Immunohistochemical findings
In MLSLC, the tumor cells were uniformly negative for
CDK4 (Fig. 3a) and MDM2 (Fig. 3b) in both lipoma-like
andmyxoid areas. OrdinaryMLS showed essentially the same
immunoreactivity as that of MLSLC. On the other hand,
WDLS (Fig. 3c, d) and DDLS were variably positive for
CDK4 and MDM2, presenting a sharp contrast to MLS with
or without lipoma-like components.
PPARγ and C/EBPαwere positive in all tumors of each LS
type (Table 2, Fig. 3e, f), but the cells expressing these pro-
teins were somewhat more common in undifferentiated
myxoid areas than in lipoma-like components. Adipophilin
was expressed in each tumor of MLSLC (Fig. 3g) and ordi-
nary MLS, although myxoid areas contained more positive
cells than lipoma-like components did. Generally, reactivity
for adipophilin was stronger in immature lipoblastic cells than
in mature fat cells. WDLS and DDLS also showed varying
positivity for adipophilin in tumor cells, but the numbers of
positive cells were usually fewer, when compared with MLS
with or without lipoma-like components. Perilipin was posi-
tive in all cases of MLSLC (Fig. 3h) and ordinaryMLS. How-
ever, because the perilipin decollated large fat vacuoles in
the cytoplasm, mature fat cells and signet ring lipoblasts as
well as multivacuolated lipoblasts revealed a stronger re-
activity, when compared with immature cells. In WDLS
and DDLS, mature fat cells and spiderweb lipoblasts
showed more intense reactivity for perilipin than undiffer-
entiated round or spindle cells did.
The Ki-67 labeling index (Table 2, Fig. 3i, j) was signifi-
cantly lower in the lipoma-like components of MLSLC
(range, 0.8–3.6; mean, 2.7; median, 2.9) than either in the
myxoid components of MLSLC (range, 7.4–20.2; mean,
12.2; median, 11.2) (p<0.001) or in the ordinary MLS (range,
6.4–22.2; mean, 14.4; median, 15.6) (p<0.001). In addition,
there was no significant difference of the Ki-67 index between
ordinary MLS and myxoid component of MLSLC.
Chromosome analysis
Chromosomal analysis with G-band technique was performed
in three cases of MLSLC and in eight cases of ordinary MLS.
A l l MLSLC t umo r s e x am i n e d d emo n s t r a t e d
t(12;16)(q13;p11) characteristic of MLS (Table 2, Fig. 4a),
although a few additional aberrations were found in some
cases. Supernumerary ring chromosomes or giant marker
chromosomes were never found in MLS with or without
lipoma-like components. On the contrary,WDLS (three cases)
and DDLS (one case) demonstrated supernumerary ring
(Fig. 4b) and/or giant marker chromosomes. In addition, a
complex karyotype was found in a case of DDLS.
FISH for detecting break apart of DDIT3
FISH was performed in all eight cases of MLSLC and in four
cases of ordinary MLS. Break apart of DDIT3 was confirmed
in each MLS regardless of lipoma-like changes (Table 2). In
MLSLC, both lipoma-like and myxoid areas of the same his-
tologic sections showed identical break-apart signals (Fig. 4c,
d). The sarcoma cells with DDIT3 break apart exhibited one
yellow (fusion signal), one green, and one red (break-apart
signal pattern), whereas normal cells (inner control such as
vascular endothelia cells) possessed a two-fusion signal pat-
tern (yellow or red and green overlapping) representing two
intact copies of the DDIT3 gene. On the other hand, WDLS
(four cases) and DDLS (six cases) lacked break-apart signals
of DDIT3. In three cases of DDLS, the break-apart signals
were uncountable because of the presence of densely packed
multiple signals.
RT-PCR for FUS-DDIT3
FUS-DDIT3 fusion transcript was found in all tumors of MLS
examined, including 8 cases of MLSLC and 11 cases of ordi-
nary MLS (Table 2). The incidence of FUS-DDIT3 fusion
variants was almost the same in MLSLC [type I, two cases
(25 %); type II, six cases (75 %)] and ordinary MLS [type I,
three cases (27 %); type II, eight cases (73 %)]. In addition,
both myxoid and lipoma-like components dissected from the
same paraffin sections of MLSLC exhibited the identical fu-
sion variant of FUS-DDIT3 (Fig. 4e). On the contrary, none of
the WDLS/DDLS showed FUS-DDIT3 fusion.
Fig. 1 Myxoid liposarcoma with extensive lipoma-like changes. The
bulk of this tumor is composed of mature adipocytes with considerable
variation in cellular size and shape, bearing superficial resemblance to
atypical lipomatous tumor/well-differentiated liposarcoma. Notice a
small amount of myxoid component with arborizing capillary blood
vessels on the lower left corner
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Discussion
LSs rarely exhibit unusual histologic features with com-
bined patterns of lipoma-like WDLS and MLS [4, 6, 12,
23]. However, the distinction between MLSLC and
WDLS/DDLS with myxoid changes is often difficult
Fig. 2 a–cMyxoid liposarcoma
(MLS) with lipoma-like changes
(MLSLC). a Focal myxoid




myxoid and lipoma-like areas. c
Myxoid area of MLSLC with
immature round cells and signet
ring lipoblasts in an abundant
myxoid stroma. d Ordinary MLS
with arborizing capillary blood
vessels. eWell-differentiated
liposarcoma with focal myxoid






sarcoma-like area of DDLS. h
Marked myxoid changes in
DDLS with arborizing capillary
blood vessels, reminiscent of
MLS
Fig. 3 Immunostaining. a, b Myxoid liposarcoma with lipoma-like
change (MLSLC) shows negative staining for CDK4 and MDM2. c, d
Well-differentiated liposarcoma exhibit nuclear expressions of CDK4 and
MDM2. e, f MLSLC shows positive nuclear staining for PPARγ and
C/EBPα. g Adipophilin is strongly positive in immature lipoblastic
cells of MLSLC. h Perilipin is positive in large fat vacuoles of mature
adipocytes and multivacuolated lipoblasts of MLSLC. i, j The Ki-67
index is very low in i the lipoma-like area of MLSLC, when compared
with j the myxoid area of the same tumor
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because of the morphologic similarities, although the ab-
sence of hyperchromatic cells in the adipocytic areas of
MLSLC may be a useful diagnostic clue [7]. The recent
advances of molecular cytogenetic techniques including
FISH and RT-PCR provide powerful tools for resolving
these problems, as shown in the present study.
Our study demonstrated that MLSLCs containing peculiar
lipoma-like components actually represent MLS, which is dif-
ferent from either true mixed-type LS or WDLS/DDLS with
myxoid changes, on the basis of molecular cytogenetic fea-
tures. Both lipoma-like and myxoid components of the same
MLSLC exhibited the identical abnormality, FUS-DDIT3 spe-
cific for MLS, which was confirmed by FISH and RT-PCR.
There was a clear cut difference between MLSLC and
WDLS/DDLS with myxoid changes; the former was positive
for t(12;16)/FUS-DDIT3 and negative for giant marker/ring
chromosomes, whereas the latter exhibited converse
characteristics.
Fig. 4 Cytogenetic and molecular analysis of liposarcoma. a Partial
karyotype of myxoid liposarcoma with lipoma-like changes
(MLSLC) (case 2) showing t(12;16)(q13;p11) (arrows indicate
derivative chromosomes resulting from the reciprocal translocation). b
Well-differentiated liposarcoma (case 21) exhibits characteristic
supernumerary ring chromosomes. c Fluorescence in situ hybridization
(FISH) detectingDDIT3 break apart in MLSLC (case 7). In a transitional
zone between myxoid (left) and lipoma-like (right) areas, both immature
round cells (arrows) and well-differentiated adipocytic cells
(arrowheads) exhibit break-apart signals of DDIT3. d Myxoid area of
MLSLC (case 8) presenting break-apart signals of DDIT3 in many
sarcoma cells. e Detection of FUS-DDIT3 fusion transcript by RT-PCR
with the FUS ex5 and DDIT3 primer set amplifying a 159-bp (FUS-
DDIT3 type II) fragment (cases 1 to 10, 13, 14, and 16) or a 435-bp
(FUS-DDIT3 type I) fragment (case 17) and the FUS ex7 and DDIT3
primer set amplifying a 128-bp (FUS-DDIT3 type I) fragment (case 7). In
each MLSLC, FUS-DDIT3 fusion transcript was found in both lipoma-
like (L) and myxoid (M) areas. Ordinary MLSs (cases 17 and 18) were
also positive for the specific FUS-DDIT3, whereas well-differentiated
(WD) and dedifferentiated (DD) liposarcomas (cases 20 and 24) showed
no fusion transcript. m, size marker, 100-bp DNA ladder; N, negative
control. In the lower lanes, the concomitant detection of β2-
microglobulin gene transcript (120 bp) confirmed the presence of
amplifiable RNA
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The occurrence of truemixed-type LSmay be very rare, if it
can exist as a distinct entity. Meis-Kindblom et al. [17]
described a series of 30 cases of LS including a case of mixed
LS, which is composed ofWDLS andMLSwith a coexistence
of ring/giant marker chromosome (characteristic of WDLS)
and t(12;16)/FUS-DDIT3 (specific for MLS). Unfortunately,
however, no FISH data from the WDLS component of the
tumor was shown in this case. Mentzel et al. [27] reported
another example of mixed-type LS consisting of ALT/WDLS
and MLS components. By FISH analysis, they found amplifi-
cations of MDM2 and CDK4 genes in ALT/WDLS areas and
translocations of DDIT3 and FUS genes in MLS areas,
although their immunohistochemical study failed to demon-
strate clear nuclear expressions of MDM2 and CDK4 in the
tumor. On the other hand, Antonescu et al. [16] suggested that
in many instances of mixed MLS+WDLS or translocation-
negative MLS, the tumors may have represented predominant-
ly myxoidWDLS or pleomorphic LS with myxoid changes, as
supported by the cytogenetic data in the respective reports.
They considered that the presence of microscopic foci of
lipoma-like or sclerosing areas, characteristic of WDLS, con-
stitutes sufficient histologic evidence to exclude the diagnosis
of MLS, as supported by the consistent absence of DDIT3 or
FUS genomic rearrangements in such tumors.
Recently, de Vreeze et al. [5] analyzed eight cases of LS
designated as mixed-type LS with combined patterns of
WDLS and MLS. By immunohistochemical and molecular
data, they concluded that these mixed-type LSs should not
be regarded as collision tumors, but as an extreme variant of
morphological entity, explaining biological contradiction of
mixed-type LS.
In the present study, FUS-DDIT3 fusion gene was found in
distinct lipoma-like components as well as myxoid areas of
MLSLC, suggesting that tumor cells of some true MLSs have
a potential to differentiate into mature adipocytes producing a
lipoma-like masses mimickingWDLS. Conversely, ring/giant
marker chromosomes as well as immunohistochemical ex-
pressions of CDK4 and MDM2 characteristic of ALT/
WDLS were never found in any case of MLS with a lipoma-
like component.
Little is known about the mechanism of adipocytic differ-
entiation in MLSLC and ordinary MLS, although various fac-
tors have been supposed to be concerned with the development
of fat cells. Some molecular studies [13, 35] suggested that
FUS-DDIT3 prevents the development of adipocytic precur-
sors in MLS by repressing PPARγ and C/EBPα. On the other
hand, based on a comparative ultrastructural and RT-PCR anal-
ysis of MLS/RCLS, Huang and Antonescu [36] found that the
variation of FUS-DDIT3 fusion transcript showed no apparent
impact on adipogenesis ofMLS, and they considered that other
factors might be implicated in their level of differentiation.
Normal adipogenesis is thought to occur in two stages:
commitment of mesenchymal stem cells to a preadipocyte
fate, followed by terminal differentiation to mature adipocytes
[29]. Adipogenic stimuli induce terminal differentiation in
committed preadipocytes through the epigenomic activation
of PPARγ. The coordination of PPARγwith C/EBP transcrip-
tion factors maintains adipocyte gene expression.
In our study, both PPARγ and C/EBPαwere found in each
type of LSs with or without mature lipoma-like components.
The results are in accord with the molecular analysis by
Tontonoz et al. [14]. Recent studies suggested that PPARγ
may regulate the expression of lipid droplet-associated pro-
teins including adipophilin and perilipin. Adipophilin associ-
ates with smaller neutral lipid storage droplets located within
many tissues, whereas perilipin is located on the surface of
larger triacylglycerol droplets in mature adipocytes and on
cholesterol ester droplets in steroidogenic cells [30, 31]. In
the present study, we found that adipophilin was strongly
expressed in tiny fat droplets of immature lipoblastic cells of
MLSLC and ordinary MLS, whereas mature adipocytes in
lipoma-like component of MLSLC exhibited weak expression
of this protein. On the other hand, perilipin showed a strong
positive staining in large fat vacuoles of signet ring and
multivacuolated lipoblasts as well as mature adipocytes in
lipoma-like components of MLSLC and WDLS, but myxoid
areas of MLSLC and DDLS contained a few cells possessing
small fat vacuoles positive for perilipin. The combined immu-
nohistochemical detection of adipophilin and perilipin may
provide a useful ancillary tool for identification of lipoblastic
cells in soft tissue sarcomas, since the former is localized in
less-differentiated lipoblasts, and the latter is confined to more
mature lipoblasts and fat cells.
Immunostaining for Ki-67 (MIB-1) demonstrated a lower
labeling index of the nuclei in lipoma-like components of
MLSLC, when compared with myxoid areas of the same tu-
mor as well as ordinary MLS (p<0.001). The results suggest
that well-differentiated tumor cells resembling mature adipo-
cytes in the lipoma-like components possess a lower level of
proliferative activity, whereas undifferentiated or poorly dif-
ferentiated cells in the myxoid areas of MLS with or without
lipoma-like components retain high proliferative activities.
The clinical behavior of LS is highly dependent on the
histologic subtype and the location of tumor [1, 2, 4, 17,
25]. The prognosis of MLS involving the deep soft tissue of
the extremities is generally favorable when appropriately
treated by a complete wide surgical excision with or without
a combined radiation or chemotherapy. In the present study,
one (20 %) of five MLSLCs followed up had a recurrent
tumor but nometastases, whereas four (44%) of nine ordinary
MLSs showed local recurrences and two (22 %) of these pa-
tients suffered from remote metastases. It cannot be denied
that MLSLCmay be less aggressive in clinical behavior when
compared with ordinary MLS, although no appropriate statis-
tical analysis could be applied in the present study because of
the insufficient numbers of the patients. A large-scale study
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with sufficient numbers of patients is required to clarify the
biological behavior of MLSLC. On the other hand, the overall
poor prognosis of retroperitoneal WDLS may result from the
frequent occurrence of dedifferentiation, in addition to late
tumor detection, involvement of vital structures, and inability
to achieve complete resection [1, 2, 25].
In conclusion, our molecular cytogenetic study enabled the
distinction between MLSLC and WDLS/DDLS with myxoid
changes. The recognition of these peculiar conditions is im-
portant, because there are considerable differences of clinical
behavior and prognosis between these distinct sarcomas pre-
senting similar morphologic features. In addition, the com-
bined immunohistochemical detection of adipophilin and
perilipin may provide a useful ancillary tool for identification
of lipoblastic cells in soft tissue sarcomas, since the former is
localized in less-differentiated lipoblasts, and the latter is
chiefly confined to more mature lipoblasts and fat cells.
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